INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)

Background Until now, no robust data supported the efficacy, safety and recommendation for influenza vaccination in patients with cancer receiving immune checkpoint inhibitors (ICIs).Methods The prospective multicenter observational INfluenza Vaccine Indication During therapy with Immune checkpoint...

Full description

Bibliographic Details
Main Authors: Diana Giannarelli, Sandro Pignata, Vincenzo Montesarchio, Massimo Di Maio, Melissa Bersanelli, Sebastiano Buti, Raffaele Giusti, Marcello Tiseo, Marco Filetti, Corrado Ficorella, Elena Verzoni, Ugo De Giorgi, Carmine Pinto, Ernesto Rossi, Evaristo Maiello, Maria R Migliorino, Annamaria Catino, Francesca Mazzoni, Francesco Grossi, Giorgia Guaitoli, Marco Maruzzo, Giuseppe Aprile, Marilena Di Napoli, Giorgia Negrini, Antonio Russo, Saverio Cinieri, Mimma Rizzo, Fable Zustovich, Vieri Scotti, Alberto Clemente, Paola Ermacora, Pamela Francesca Guglielmini, Antonello Veccia, Chiara Casadei, Francesco Verderame, Lucia Fratino, Caterina Accettura, Manlio Mencoboni, Cinzia Baldessari, Andrea Camerini, Letizia Laera, Mariella Sorarù, Paolo Andrea Zucali, Valentina Guadalupi, Francesco Leonardi, Michele Tognetto, Francesco Di Costanzo, Francesco di Costanzo, Roberto Labianca, Luigi Bernardi
Format: Article
Language:English
Published: BMJ Publishing Group 2021-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/5/e002619.full

Internet

https://jitc.bmj.com/content/9/5/e002619.full

Similar Items